Van Eck Associates Corp Ionis Pharmaceuticals Inc Transaction History

Van Eck Associates Corp

  • $88.3 Billion
  • Q2 2025

A detailed history of Van Eck Associates Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 73,617 shares of IONS stock, worth $5.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,617
Previous 2,157 3312.93%
Holding current value
$5.41 Million
Previous $65,000 4375.38%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$25.51 - $40.0 $1.82 Million - $2.86 Million
71,460 Added 3312.93%
73,617 $2.91 Million
Q1 2025

May 15, 2025
SELL
$30.17 - $34.97 $1.79 Million - $2.08 Million
-59,462 Reduced 96.5%
2,157 $65,000
Q4 2024

Jan 29, 2025
BUY
$33.73 - $40.36 $88,136 - $105,460
2,613 Added 4.43%
61,619 $2.15 Million
Q3 2024

Oct 29, 2024
BUY
$40.06 - $51.86 $350,204 - $453,360
8,742 Added 17.39%
59,006 $2.27 Million
Q2 2024

Jul 31, 2024
SELL
$36.45 - $47.7 $1.49 Million - $1.95 Million
-40,837 Reduced 44.83%
50,264 $2.4 Million
Q1 2024

Apr 30, 2024
BUY
$42.03 - $53.55 $1.06 Million - $1.35 Million
25,270 Added 38.39%
91,101 $3.95 Million
Q4 2023

Feb 05, 2024
BUY
$43.39 - $51.63 $49,638 - $59,064
1,144 Added 1.77%
65,831 $3.33 Million
Q3 2023

Nov 08, 2023
BUY
$38.5 - $47.13 $1.28 Million - $1.57 Million
33,326 Added 106.27%
64,687 $2.93 Million
Q2 2023

Aug 03, 2023
BUY
$34.73 - $43.33 $423,219 - $528,019
12,186 Added 63.55%
31,361 $1.29 Million
Q1 2023

May 03, 2023
BUY
$33.58 - $41.2 $239,526 - $293,879
7,133 Added 59.23%
19,175 $685,000
Q4 2022

Feb 08, 2023
BUY
$37.12 - $46.52 $394,400 - $494,275
10,625 Added 749.82%
12,042 $455,000
Q3 2022

Oct 27, 2022
BUY
$36.54 - $48.66 $51,777 - $68,951
1,417 New
1,417 $63,000
Q3 2021

Nov 03, 2021
SELL
$33.54 - $40.55 $4.94 Million - $5.98 Million
-147,383 Closed
0 $0
Q2 2021

Aug 10, 2021
SELL
$34.54 - $47.25 $780,914 - $1.07 Million
-22,609 Reduced 13.3%
147,383 $5.88 Million
Q1 2021

May 13, 2021
BUY
$42.51 - $63.78 $1.84 Million - $2.76 Million
43,349 Added 34.23%
169,992 $7.64 Million
Q4 2020

Feb 09, 2021
BUY
$45.3 - $60.27 $32,842 - $43,695
725 Added 0.58%
126,643 $7.16 Million
Q3 2020

Nov 12, 2020
SELL
$47.45 - $62.95 $807,171 - $1.07 Million
-17,011 Reduced 11.9%
125,918 $5.98 Million
Q2 2020

Aug 10, 2020
BUY
$46.85 - $61.05 $2.87 Million - $3.73 Million
61,163 Added 74.8%
142,929 $8.43 Million
Q1 2020

May 12, 2020
SELL
$41.6 - $63.4 $923,312 - $1.41 Million
-22,195 Reduced 21.35%
81,766 $3.87 Million
Q4 2019

Feb 13, 2020
SELL
$53.85 - $65.27 $67,689 - $82,044
-1,257 Reduced 1.19%
103,961 $6.28 Million
Q3 2019

Nov 08, 2019
BUY
$59.06 - $72.15 $78,904 - $96,392
1,336 Added 1.29%
105,218 $6.3 Million
Q2 2019

Aug 07, 2019
SELL
$62.09 - $86.14 $1.15 Million - $1.59 Million
-18,491 Reduced 15.11%
103,882 $6.68 Million
Q1 2019

May 13, 2019
SELL
$52.92 - $81.17 $555,818 - $852,528
-10,503 Reduced 7.9%
122,373 $9.93 Million
Q4 2018

Feb 12, 2019
SELL
$43.37 - $59.54 $199,285 - $273,586
-4,595 Reduced 3.34%
132,876 $7.18 Million
Q3 2018

Nov 13, 2018
BUY
$42.88 - $53.7 $33,232 - $41,617
775 Added 0.57%
137,471 $7.09 Million
Q2 2018

Aug 13, 2018
BUY
$40.53 - $50.7 $871,800 - $1.09 Million
21,510 Added 18.67%
136,696 $5.7 Million
Q1 2018

May 11, 2018
SELL
$44.08 - $55.05 $2.39 Million - $2.98 Million
-54,161 Reduced 31.98%
115,186 $5.08 Million
Q4 2017

Feb 12, 2018
SELL
$50.3 - $64.39 $4.44 Million - $5.69 Million
-88,358 Reduced 34.29%
169,347 $8.52 Million
Q3 2017

Nov 09, 2017
BUY
$45.56 - $59.57 $844,910 - $1.1 Million
18,545 Added 7.75%
257,705 $13.1 Million
Q2 2017

Aug 11, 2017
BUY
N/A
239,160
239,160 $12.2 Million

Others Institutions Holding IONS

# of Institutions
429
Shares Held
149M
Call Options Held
1.72M
Put Options Held
722K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $10.4B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email